Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Are You Under Attack By Howard Bloom

    November 20, 2026

    The Odysseys Blu-ray Is Missing One Major Extra, But Christopher Nolan Has A Good Reason

    November 20, 2026

    The Traitors: New Blood: Jay Vinnedge on Being the King of Chaos & His Supsicions of Katie

    November 20, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Business»Here’s why it’s time to buy ‘dividend aristocrats,’ says Wolfe Research
    Business

    Here’s why it’s time to buy ‘dividend aristocrats,’ says Wolfe Research

    By AdminNovember 28, 2023
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Here’s why it’s time to buy ‘dividend aristocrats,’ says Wolfe Research

    [ad_1]

    Next year could be the year for certain dividend stocks, according to Wolfe Research. As a whole, dividend stocks underperformed the market this year as investors found income elsewhere, thanks to near historic yields in the bond market. Bond yields move inversely to prices. That’s about to change, predicted analyst Chris Senyek. While it is unclear whether the Federal Reserve will hike interest rates one more time this year, the market is convinced the central bank is done. Fed funds futures pricing data suggests a 96.5% probability that rates will stay unchanged at their current 5.25%-5.50%, according to the CME FedWatch Tool . That means an environment where interest rates are higher for longer, followed by rate cuts. “Dividend themes generally performed well after the final hike in a Fed tightening cycle, with Dividend Aristocrats performing the best,” Senyek wrote in a note Monday. The S & P 500 Dividend Aristocrats Index is composed of companies that have increased dividends for at least 25 consecutive years. “We attribute this to risk off episodes/economic growth slowing that often occurs after the last hike and between the first cut,” he added. In fact, Senyek called dividend aristocrats the firm’s top dividend investment strategy. “During economic slowdowns or recessionary environments, our favorite dividend focused strategy is buying companies with a long track record of consistently increasing dividends, a.k.a., dividend aristocrats,” he wrote. “This cohort of stocks has generally outperformed heading into and out of recessions.” The stocks are concentrated in consumer staples, which account for 25% of the index, and industrials, which make up 23%, per Wolfe Research. Materials make up 12%, while financials are 11% of the index. They are also trading as a group cheaper than the overall market, Senyek pointed out. Dividend aristocrats’ relative price-to-earnings ratio versus the S & P 500 is currently 0.89 times, cheaper than the long-term average of 1.03 times, he said. Here are some of the names in the S & P 500 Dividend Aristocrats Index. Walgreens yields 9.5% but has had a dismal year, with a total return of about -42%. The pharmacy chain, struggling with falling demand for Covid vaccines and tests, has been attempting to transition to a health-services provider. In 2021, it became majority owner of primary-care company VillageMD. Since that time, Walgreens also acquired Shields Health, a specialty pharmacy, and CareCentrix, a homecare provider. CEO Roz Brewer stepped down in September and a month later, Tim Wentworth was named as her successor . Shortly before Wentworth took the helm, Walgreens reported fiscal fourth-quarter earnings that missed analysts’ expectations and issued soft profit guidance. However, the company beat on revenue for the quarter. Meanwhile, Coca-Cola beat estimates for its third-quarter earnings and revenue in late October. The beverage giant also raised its full-year outlook. Shares have a total return of -5.97% year to date and a 3.4% dividend yield. Lastly, Medtronic ‘s stock has seen a total return of more than 4% so far this year. The medical-equipment maker posted better-than-expected earnings and revenue last week. Medtronic has a dividend yield of 3.4%. For investors who prefer funds, they can also get exposure through the ProShares S & P 500 Dividend Aristocrats exchange-traded fund. The ETF currently yields 2.14%. NOBL YTD mountain ProShares S & P 500 Dividend Aristocrats ETF — CNBC’s Michael Bloom contributed reporting.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleTarget Learned Nothing From Their Pride Fiasco — Hires ‘Gay Cruella’ for LGBTQ Marketing | The Gateway Pundit
    Next Article See Walton Goggins as The Ghoul

    RELATED POSTS

    My industry wants you to gut your sales team and replace it with AI. One of my customers plans to double theirs instead | Fortune

    October 27, 2026

    The Taiwan Strait is not on the verge of war: The 2027 invasion countdown is a mirage | Fortune

    October 27, 2026

    Twilio CMO: We shrank 2 weeks of work down to one day with AI. Then the unsexy work began | Fortune

    October 26, 2026

    Goldman Sachs CEO David Solomon on AIs economic impact: Theres very little that we do where we need frontier models | Fortune

    October 26, 2026

    Nasdaq CEO calls for a national strategy as global fraud losses reach $579B | Fortune

    October 25, 2026

    Michael Burry of The Big Short was asked to give advice to Gen Z: Buy half the house you can afford, and If it flies or floats, rent it | Fortune

    October 25, 2026
    latest posts

    Are You Under Attack By Howard Bloom

    This has been a big six weeks for what looks like sabotage. It started with…

    The Odysseys Blu-ray Is Missing One Major Extra, But Christopher Nolan Has A Good Reason

    November 20, 2026

    The Traitors: New Blood: Jay Vinnedge on Being the King of Chaos & His Supsicions of Katie

    November 20, 2026

    Chvrches share tongue-in-cheek new single Evil and announce UK album launch shows in churches

    November 19, 2026

    Fantasy and Science Fiction Books Where the Rules Dont Apply – NewInBooks

    November 19, 2026

    Power Trip Unveil New Song Mutual Death Warrant via GTA 6

    November 19, 2026

    Anthropics IPO puts AIs circular financing boom to the test | TechCrunch

    November 19, 2026
    Categories
    • Books (1,593)
    • Business (6,481)
    • Events (85)
    • Film (6,456)
    • Lifestyle (4,505)
    • Music (6,590)
    • Politics (6,448)
    • Science (5,858)
    • Technology (6,446)
    • Television (6,149)
    • US News (6,491)
    popular posts

    Jax Taylor Still Sleeps In Home With Brittany Cartwright, Why?

    [ad_1] Jax Taylor has revealed that he still sleeps in the home he once shared…

    Porsche is adding an all-electric Cayenne coupe to its lineup

    April 24, 2026

    ‘One Is Too Many’: Challenges Persist In Veteran Suicide Prevention

    March 19, 2023

    Leah Remini to Replace Matthew Morrison as Season 17 Judge

    June 11, 2022
    Archives
    Browse By Category
    • Books (1,593)
    • Business (6,481)
    • Events (85)
    • Film (6,456)
    • Lifestyle (4,505)
    • Music (6,590)
    • Politics (6,448)
    • Science (5,858)
    • Technology (6,446)
    • Television (6,149)
    • US News (6,491)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Power Trip Unveil New Song Mutual Death Warrant via GTA 6

    November 19, 2026

    Anthropics IPO puts AIs circular financing boom to the test | TechCrunch

    November 19, 2026

    Jax Taylor Reveals Cancer Diagnosis, Has Major Surgery

    November 19, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT